北川 賢

Medicine & Life Sciences

1. olcegepant 100%
2. Photophobia 97%
3. Opticospinal Multiple Sclerosis 93%
4. Migraine Disorders 76%
5. Myelin-Oligodendrocyte Glycoprotein 73%
6. Sumatriptan 70%
7. Myasthenia Gravis 59%
8. Hyperalgesia 55%
9. Mycobacterium bovis 54%
10. neurotropin 45%
11. Antibodies 33%
12. Light 29%
13. Methylprednisolone 22%
14. Spinal Cord 20%
15. Urinary Bladder Neoplasms 19%
16. Oligoclonal Bands 18%
17. Pyridostigmine Bromide 14%
18. Cervical Cord 14%
19. Epilepsy 14%
20. Paresis 13%
21. Calcitonin Gene-Related Peptide Receptor Antagonists 13%
22. Penicillamine 13%
23. Pharmaceutical Preparations 12%
24. Diplopia 12%
25. Serotonin 5-HT1 Receptor Agonists 11%
26. Migraine without Aura 11%
27. Cholinergic Receptors 11%
28. Migraine with Aura 11%
29. Therapeutics 11%
30. Cerebrospinal Fluid 11%
31. Visual Acuity 10%
32. Prednisolone 10%
33. Leg 10%
34. Somatoform Disorders 10%
35. Calcitonin Gene-Related Peptide 9%
36. Immunotherapy 8%
37. Locomotion 8%
38. Inbred C57BL Mouse 7%
39. Chronic Pain 7%
40. Headache 7%
41. Theoretical Models 6%
42. Brain 6%